Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents
NCT ID: NCT01268371
Last Updated: 2014-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
1462 participants
INTERVENTIONAL
2010-12-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions
NCT01186120
Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents
NCT01068106
NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial
NCT01303640
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
NCT01267734
Comparison of the Everolimus Eluting With the Biolimus A9 Eluting Stent
NCT01233453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Promus Element
Everolimus-eluting stent
Promus Element, Boston Scientific Corporation
Everolimus-eluting stent
Nobori
Biolimus-eluting stent with biodegradable polymer
Nobori, Terumo Corporation (Japan)
Biolimus-eluting stent with biodegradable polymer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Promus Element, Boston Scientific Corporation
Everolimus-eluting stent
Nobori, Terumo Corporation (Japan)
Biolimus-eluting stent with biodegradable polymer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable angina, unstable angina, Non-ST elevation myocardial infarction (NSTEMI) and documented silent ischemia
* Patients eligible for intracoronary stenting
* age ≥ 20 years old
Exclusion Criteria
* Low ejection fraction (\< 25%)
* Cardiogenic shock
* History of bleeding diathesis or known coagulopathy
* Limited life-expectancy (less than 1 year) due to combined serious disease
* Contraindication to heparin, sirolimus, everolimus and biolimus
* Contraindication to aspirin and clopidogrel
* Pregnancy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jea Tahk
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seung-Jea Tahk, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Sejong Hospital
Bucheon-si, , South Korea
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, , South Korea
Soon Chun Hyang University Hospital Cheonan
Cheonan, , South Korea
Kangwon National University Hospital
Chuncheon, , South Korea
Daegu Catholic University Medical Center
Daegu, , South Korea
Keimyung University Dongsan Hospital
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
Konyang University Hospital
Daejeon, , South Korea
Gangneung Asan Hospital
Gangneung, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Inje University ilsan Paik Hospital
Ilsan, , South Korea
Gachon University Gil Hospital
Incheon, , South Korea
Cheju Halla General Hospital
Jeju City, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Hallym University Hankang Sacred Heart Hospital
Seoul, , South Korea
Hallym University Kangdong Sacred Heart Hospital
Seoul, , South Korea
Kyunghee University Medical Center
Seoul, , South Korea
The Catholic University of Korea Seoul ST. Mary's Hospital
Seoul, , South Korea
Yonsei University Gangnam Severance Hospital
Seoul, , South Korea
St. Carollo Hospital
Suncheon, , South Korea
Ajou University Medical Center
Suwon, , South Korea
Catholic University ST. Vincent's Hospital
Suwon, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Yonsei University Wonju College of Medicine Wonju Christion Hospital
Wŏnju, , South Korea
Pusan National University Yangsan Hospital
Yangsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BESS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.